Description

Carbonic Acid, 1-[3-[4-(Benzyloxy)-3-Bromophenyl]Propyl]-3,4-Dihydro-6-Methoxy-7-Isoquinolyl Ethyl Ester (8Ci) is a complex, high-purity synthetic organic compound designed for advanced research and development. This specialty chemical serves as a critical intermediate in the synthesis of novel pharmacologically active molecules, offering precise structural control for medicinal chemistry programs. It is primarily utilized by pharmaceutical R&D laboratories, biotechnology firms, and academic research institutions focused on developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly in central nervous system (CNS) and cardiovascular research.
• Medicinal Chemistry Research: Used for structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties of lead compounds.
• Chemical Biology Probe Development: Serves as a precursor for creating molecular probes to study specific enzyme or receptor targets in biological systems.
• Process Chemistry Development: Employed in scaling up synthetic routes for potential Active Pharmaceutical Ingredients (APIs) during process optimization phases.
• Academic Research: Utilized in university and institutional labs for investigating new synthetic methodologies and heterocyclic chemistry.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical and biotech companies with custom synthesis projects.

Basic Information

Product Name	Carbonic Acid, 1-[3-[4-(Benzyloxy)-3-Bromophenyl]Propyl]-3,4-Dihydro-6-Methoxy-7-Isoquinolyl Ethyl Ester (8Ci)
CAS No.	22320-18-9
Molecular Formula	C29H30BrNO5
Molecular Weight	552.46 g/mol
Synonyms	1-[3-[4-(Benzyloxy)-3-bromophenyl]propyl]-3,4-dihydro-6-methoxy-7-isoquinolyl ethyl carbonate; Ethyl 1-[3-[4-(benzyloxy)-3-bromophenyl]propyl]-3,4-dihydro-6-methoxy-7-isoquinolinecarboxylate; 8CI compound 22320-18-9; 1-(3-(4-(Benzyloxy)-3-bromophenyl)propyl)-6-methoxy-3,4-dihydro-7-isoquinolinyl ethyl carbonate; Carbonic acid ethyl 1-[3-[4-(benzyloxy)-3-bromophenyl]propyl]-3,4-dihydro-6-methoxy-7-isoquinolyl ester
EINECS	Contact for details

Quality Control

Our Carbonic Acid, 1-[3-[4-(Benzyloxy)-3-Bromophenyl]Propyl]-3,4-Dihydro-6-Methoxy-7-Isoquinolyl Ethyl Ester (8Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive; prolonged exposure to light should be avoided to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.